1. Home
  2. TIL vs CMT Comparison

TIL vs CMT Comparison

Compare TIL & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • CMT
  • Stock Information
  • Founded
  • TIL 2018
  • CMT 1996
  • Country
  • TIL United States
  • CMT United States
  • Employees
  • TIL N/A
  • CMT N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • CMT Electronic Components
  • Sector
  • TIL Health Care
  • CMT Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • CMT Nasdaq
  • Market Cap
  • TIL 177.1M
  • CMT 166.5M
  • IPO Year
  • TIL 2021
  • CMT N/A
  • Fundamental
  • Price
  • TIL $31.50
  • CMT $19.73
  • Analyst Decision
  • TIL Buy
  • CMT
  • Analyst Count
  • TIL 6
  • CMT 0
  • Target Price
  • TIL $120.50
  • CMT N/A
  • AVG Volume (30 Days)
  • TIL 109.0K
  • CMT 22.2K
  • Earning Date
  • TIL 08-13-2025
  • CMT 11-04-2025
  • Dividend Yield
  • TIL N/A
  • CMT N/A
  • EPS Growth
  • TIL N/A
  • CMT N/A
  • EPS
  • TIL N/A
  • CMT 1.08
  • Revenue
  • TIL N/A
  • CMT $276,176,000.00
  • Revenue This Year
  • TIL N/A
  • CMT N/A
  • Revenue Next Year
  • TIL N/A
  • CMT $6.42
  • P/E Ratio
  • TIL N/A
  • CMT $18.39
  • Revenue Growth
  • TIL N/A
  • CMT N/A
  • 52 Week Low
  • TIL $10.80
  • CMT $12.25
  • 52 Week High
  • TIL $92.00
  • CMT $19.79
  • Technical
  • Relative Strength Index (RSI)
  • TIL 61.57
  • CMT 69.03
  • Support Level
  • TIL $26.69
  • CMT $18.64
  • Resistance Level
  • TIL $28.85
  • CMT $19.41
  • Average True Range (ATR)
  • TIL 2.16
  • CMT 0.56
  • MACD
  • TIL 0.43
  • CMT 0.08
  • Stochastic Oscillator
  • TIL 76.70
  • CMT 100.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

Share on Social Networks: